Drugs like Ritalin and Adderal are widely used, not just by adults and university students, but increasingly by children, and not just those who are appropriately diagnosed as experience difficulites with attention or focus, such as Attention Deficit Disorder.
PHOTO: Ritalin SR (a brand-name sustained-release formulation of methylphenidate, from Wikimedia, 16 June 2006, created by Sponge.
Perviously, the AAN raised concerns drug enhancement by adults. It concluded that there is no moral basis for objecting, provided that the patient is acting autonomously in requesting the prescription. But when it comes to prescribing for healthy children, the AAN report makes this claim: "Pediatric neuroenhancement remains a particularly unsettled and value-laden practice, often without appropriate goals or justification."
The Report notes that enhancing children is fundamentally different from enhancing adults. For doctors, it raises concerns for "the fiduciary responsibility of physicians caring for children, the special integrity of the doctor–child–parent relationship, the vulnerability of children to various forms of coercion, distributive justice in school settings, and the moral obligation of physicians to prevent misuse of medication."
Based on these concerns, the AAN Report advises that "the prescription of neuroenhancements is inadvisable because of numerous social, developmental, and professional integrity issues."
The primary objection raised by the AAN is that children lack the competency to act as autonomous moral agents. If they were competent, then their request for enhancement would be honored. Sure, children can be coerced, manipulated, confused, and ambivalent about their needs. Kind of like the rest of us.
Whether age brings moral competence is a good question. But perhaps what this report shows us once again is that when secular bioethics meets enhancement technology, about all it can say is this: If you want it and if you can prove your competence, you can have it.
The AAN report, “Pediatric neuroenhancement: Ethical, legal,social, andneurodevelopmental implications,” is published in the March 13, 2013
issue of Neurology.
No comments:
Post a Comment